|
Further references used to develop this protocol:
Erlic, Z., L. Rybicki, M. Peczkowska, et al. 2009. "Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients." Clin Cancer Res 15(20):6378-6385
King, K. S., T. Prodanov, V. Kantorovich, et al. 2011. "Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations." J Clin Oncol 29(31):4137-4142.
Mannelli, M., M. Castellano, F. Schiavi, et al. 2009. "Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas." J Clin Endocrinol Metab 94(5):1541-1547.
Jafri, M., J. Whitworth, E. Rattenberry, et al. 2013. "Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma." Clin Endocrinol (Oxf) 78(6):898-906.
Korpershoek, E., J. Favier, J. Gaal, et al. 2011. "SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas." J Clin Endocrinol Metab 96(9):E1472-1476.
Buffet, A., A. Venisse, V. Nau, et al. 2012. "A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma." Horm Metab Res 44(5):359-366.
Cascon, A., E. Lopez-Jimenez, I. Landa, et al. 2009. "Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma." Horm Metab Res 41(9):672-675
Fakhry, N., P. Niccoli-Sire, A. Barlier-Seti, et al. 2008. "Cervical paragangliomas: is SDH genetic analysis systematically required?" Eur Arch Otorhinolaryngol 265(5):557-563
Gill, A. J., D. E. Benn, A. Chou, et al. 2010. "Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes." Hum Pathol 41(6):805-814
Hao, H. X., O. Khalimonchuk, M. Schraders, et al. 2009. "SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma." Science 325(5944):1139-1142
Qin, Y., L. Yao, E. E. King, et al. 2010. "Germline mutations in TMEM127 confer susceptibility to pheochromocytoma." Nat Genet 42(3):229-233
August 2012 - Further references used during the review of this protocol
Korpershoek, E., J. Favier, J. Gaal, et al. 2011. "SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas." J Clin Endocrinol Metab 96(9):E1472-1476
Amar, L., J. Bertherat, E. Baudin, et al. 2005. "Genetic testing in pheochromocytoma or functional paraganglioma." J Clin Oncol 23(34):8812-8818
Gimenez-Roqueplo, A. P., H. Lehnert, M. Mannelli, et al. 2006. "Phaeochromocytoma, new genes and screening strategies." Clin Endocrinol (Oxf) 65(6):699-705
Neumann, H. P., M. Sullivan, A. Winter, et al. 2011. "Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites." J Clin Endocrinol Metab 96(8):E1279-1282
Hensen, E. F., N. van Duinen, J. C. Jansen, et al. 2011. "High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands." Clin Genet.
Eisenhofer, G., J. W. Lenders, H. Timmers, et al. 2011. "Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma." Clin Chem 57(3):411-420
Fishbein, L. and K. L. Nathanson. 2012. "Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background." Cancer Genet 205(1-2):1-11
|